From: Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma
Reagent
HCC827
H23
H520
IC50
OTSSP167
22
18
13
Reversine
350
1300
5300
CI
OTSSP167 + Aura
0.777
0.795
0.783
Reversine + Aura
1.063
1.130